Surgery in Oral Medicine: Biopsy of Oral Lesions

Biopsy: what it is + why it matters

  • Definition: Removal of cells/tissue from a living patient for microscopic diagnosis by a pathologist.
  • Purposes
    • Definitive diagnosis
    • Stage/severity assessment
    • Treatment planning

Indications for biopsy (oral tissue)

CategoryBiopsy is indicated when…Examples / high-yield flags
Persistent mucosal abnormalityLesion persists despite removing irritants/conservative carePersists > 2 weeks with no obvious cause
Suspicion of malignancyConcerning clinical featuresRed/white (speckled), ulcerated, indurated, fixed, bleeds easily, rapid growth
Pigmented lesionNew or changing pigmentation without explanationIf documented stable >5 years, biopsy may not be required
Functional/systemic indicatorsLesion affects function or suggests systemic diseaseTrismus; sudden tooth loosening (esp younger → consider Langerhans cell histiocytosis); persistent swelling with normal mucosa (e.g. lymphoma)
Hard tissue lesionsNot diagnosable by clinical + radiographic features aloneBone lesions needing histologic diagnosis

Contraindications / “don’t biopsy here—think risk or refer”

No absolute contraindications, but proceed only after risk assessment and considering referral.

DomainHigher risk situationsPractical action
Medical statusAnticoagulation, immunocompromise, frailty, significant comorbidity/polypharmacyOptimise/plan bleeding & infection risk; consider specialist
Access/complexityDifficult access, equipment needs, operator skill limitations; lesions needing GA/airway controlRefer if beyond scope/setting
High suspicion malignancyConcern that biopsy pathway may delay definitive careEarly specialist referral may be best
Suspected vascular lesionHemangioma/AVM risk of uncontrolled bleedingDo not biopsy in clinic → controlled setting/specialist

Suspicious lesion pathway (practical)

  • If low suspicion: consider 10–14 days observation/nonsurgical management.
  • If high suspicion or specific disease strongly suspected: do not waitbiopsy or refer immediately.
  • If no improvement after observation:
    • Biopsy (then manage vs refer based on result/complexity), or
    • Refer for specialist workup.

Important

Immediate biopsy/referral is required for lesions highly suspicious for malignancy (don’t wait out an observation period).


Patient assessment (history)

History domainWhat to documentWhy it matters
Duration + awarenessNew vs longstanding; incidental findingLongstanding lesions often more benign (not always)
ChangeGrowth rate; change in character (e.g., mass ulcerating; vesicle → ulcer)Rapid change can signal aggressive disease
SymptomsPain, altered sensation, taste change, odour, dysphagia, trismusHelps triage severity + DDx
SiteExact location; keratinised vs non-keratinisedSite predilections guide DDx
Systemic contextFever, malaise, nausea; recent dental tx/chemical exposureInfection/systemic disease/iatrogenic clues
Broader contextTrauma, new meds, toxins, travel; consider viral/autoimmune/STIsSome conditions need tests other than biopsy

Medical / medication / allergy history

  • Medical history: systemic illness may present orally; sometimes other tests are more appropriate than biopsy.
  • Medication-related oral conditions to consider
    • Stevens–Johnson syndrome
    • Aspirin burn
    • Petechiae (notably in patients on anticoagulants)
  • Allergies: antibiotics, NSAIDs, iodine, other; include food triggers if relevant.

Clinical examination (inspection + palpation)

Tissue of origin (helps differential)

  • Mucosa/epithelium, submucosal connective tissue, muscle/tendon, nerve, bone, blood vessels, lymphatics/salivary glands.

Lesion morphology (describe what you see)

  • Vesicle/bulla/pustule; crust/scale/erosion
  • Ulcer/stomatitis
  • Macule/papule/nodule/plaque
  • Hyperkeratosis/leukoplakia; hyperplastic lesions
  • Dysplasia/malignancy patterns

Single vs multiple; distribution

  • Single vs multiple (infection/trauma/autoimmune considerations).

Size/shape/growth pattern

FeatureOptions
MarginsRegular / irregular
GrowthExophytic / endophytic
AttachmentSessile / pedunculated

Surface + colour

  • Surface texture: smooth / verruciform / irregular
  • Ulcer: rolled/flat/raised/everted margins; base may be fibrin/slough/granulation/hemorrhagic scab
  • Colour clues:
    • Dark blue/pulsatile → consider vascular lesion/AVM
    • Blue → mucous retention cyst mimic
    • Pigmented → tattoo → melanotic tumour spectrum
    • Red lesions can represent more severe dysplasia than white lesions

Mobility/consistency/pulsation

Exam elementKey interpretations
MobilityFixed to deep tissues vs mobile (origin vs infiltration)
ConsistencySoft/compressible (lipoma/abscess/mucous retention cyst); firm/indurated (fibroma/malignancy); hard (bony exostosis); fluctuant (fluid cavity)
PulsationSuggests vascular lesion; bluish + pulsation → consider AVM

Lymph nodes

  • Assess lymphadenopathy; location can suggest spread pattern.

Documentation standard

  • Record location/orientation, size, shape (diagram acceptable).
  • Photographs recommended; sequential photography helps detect progression.

Features suspicious of malignancy (red flags)

Red flagWhat to look for
Duration>2 weeks or progressive worsening
ColourErythroplasia or speckled red/white
UlcerationPersistent ulcer
IndurationFirm lesion/surrounding tissues
FixationAttached to adjacent structures
BleedingOn gentle manipulation
GrowthRapid enlargement

Biopsy principles + classification

General principles

  • Biopsy when a definitive diagnosis cannot be obtained via less invasive methods (e.g., cytology/brush cytology/FNA).
  • Clinical pearl: Gentle handling prevents crush/haemorrhage artefact that reduces diagnostic accuracy.

Types of biopsy (overview)

CategoryMethods
Surgical (general practice focus)Punch, incisional, excisional
Specialist diagnostic techniquesFNAC, core biopsy, cytology/brush biopsy, frozen section

Biopsy procedure (standard steps)

  1. Identify and mark biopsy area; photograph
  2. Surgical preparation (e.g., chlorhexidine/iodine as appropriate)
  3. Local anaesthesia
  4. Obtain specimen
  5. Specimen handling/preservation
  6. Wound management

Technique selection (punch vs incisional vs excisional)

Quick comparison

TechniqueBest forKey points / pitfalls
Punch biopsyBound-down soft tissue (gingiva, alveolar mucosa, hard palate)Sizes often 3–6 mm; twist to core; grasp and cut base; more tedious on mobile tissue (cheek/tongue/FOM)
Incisional biopsyLarge, mixed-character lesions; suspected malignancyTake representative “worst-looking” area; include lesion + normal margin + adequate depth; may need multiple samples
Excisional biopsySmall lesions that can be removed with margin without distortion; clinically benign-appearingRemove entire lesion with ~2–5 mm margin; orient specimen (suture) for margins/re-excision planning

Warning

Incisional biopsies can suffer from crush/haemorrhage artefact if poorly handled.

Incisional biopsy: practical sampling rules

  • Prefer deep specimen (avoid broad/shallow).
  • Sample junction of lesion + normal tissue (especially for ulcers).
  • Consider orientation suture for localisation if margins involved later.

Excisional biopsy: incision geometry (practical)

  • Elliptical incision with ≥ 3 mm from lesion border (where feasible).
  • Incisions converge into depth (V-shaped cross-section) to aid closure.
  • Hard palate may require secondary intention healing.

Fine needle aspiration (FNA): where it fits

UseWhy it’s helpful
Fluctuant lesionsSamples fluid/cells with minimal morbidity
Lymph nodesCytology support
Deep lesions (often imaging-detected)Often ultrasound-guided
Rule out vascular lesionSignificant blood backflow suggests vascularity

Specimen handling + transport (what the lab needs)

Pathology request: must include

ItemDetails to provide
Patient detailsAccurate identifiers
Test requestedHistopathology vs cytology
Clinical notesExact site, duration, size/change, appearance, symptoms, differential diagnosis

Info

Pathologists typically see only the specimen (not the patient)your clinical notes are critical.

Transport media

PurposeMedium
Routine histology (H&E)10% buffered formalin
Direct immunofluorescence (DIF)Saline-soaked gauze in sterile pot (time-sensitive) or Michel’s medium
Microbiology cultureFresh sterile container (no fixative); contact lab if unsure

Labelling checklist

  • Patient identifiers match form
  • Precise anatomical site
  • Time/date of procedure

Practical template: Incisional biopsy (chairside checklist)

  • Describe lesion: site, size, colour/surface, duration, symptoms, growth rate.
  • Anaesthesia: inject peripheral to avoid distortion.
  • Technique: wedge/deep ellipse including lesion + small normal margin + depth.
  • Handling: fine forceps or traction suture; avoid crush.
  • Hemostasis/closure: document method + suture type/number.
  • Specimen: formalin (unless DIF/microbiology planned).
  • Orientation: document suture position (e.g., “suture marks anterior”); photograph with ruler when possible.
  • Follow-up: results review + suture removal appointment.

Example pathology report: what to extract clinically

  • Specimen site + size + orientation method
  • Diagnosis (incl. dysplasia grade/cancer type)
  • Margin status (e.g., dysplasia to margin)
  • Recommendation: clinical correlation / further excision as indicated

Tip

If unsure about diagnosis, vascularity, surgical access, airway risk, or malignancy suspicion → refer early to OMFS/oral medicine. </smtcmp_block>